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ABSTRACT
Background The incorrect use ofmedicationsmay
result from improper prescribing. The poor inter-
face and design of computerised physician order
entry (CPOE) systems may contribute. To improve
the quality of electronic drug prescription,
ePrescribing, there is a need for an evaluationmodel
that is able to assess the quality of the CPOE,
focusing on usability.
Objective To develop and apply a model to evalu-
ate the usability of diﬀerent CPOEs used for
ePrescribing in electronic health records (EHRs)
in primary care.
Method An evaluation model for CPOEs was
designed by assembling existing quality criteria for
ePrescribing, supplemented with new criteria. The
evaluation model was used to assess CPOEs from
seven EHRs in primary care.
Results The evaluation model included ﬁve cate-
gories comprising 73 single criteria. The model was
found to be easy to use, and facilitated the assess-
ment process. Evaluation of the EHRs revealed
diﬀerences and similarities between the systems.
None of the CPOEs was perfect in that all of them
had distinct shortcomings. The most prominent
deﬁciencies were a non-intuitive interface and in-
correct dosage function.
Conclusion The model developed might be used
not only to evaluate usability in ePrescribing, but
also as a basis for studying the usability of other
CPOEs. To reduce the risk of drugs being prescribed
with incorrect dosages, the most urgent improve-
ment is the development of a more consistent and
intuitive interface for the EHRs and an improve-
ment in the dosage function.
Keywords: computerised, electronic prescribing,
medical record system, primary health care, pro-
gram evaluation/methods
What this paper adds
. A new evaluation model for studying the usability of computerised order entry (CPOE).
. Criteria for the assessment of ePrescribing are deﬁned.
. Application of the model reveals shortcomings among diﬀerent CPOEs.
. By ﬁxing the deﬁciencies identiﬁed, patient safety might be improved and frustration among users
reduced.
. The evaluation model might be employed for the assessment of new and updated CPOEs in other areas
than ePrescribing.
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Introduction
Drugs that are incorrectly prescribed increase risk for
the patient aﬀected and are a considerable cost to
society.1 Examples of prescription errors may be
incorrect dose formulation,2 incorrect treatment dur-
ation, the absence of clear instructions to the patient3
and prescription to the wrong patient.4
The use of electronic prescribing, ePrescribing, is
increasing worldwide, often accompanied by decision
support systems. These support systems may reduce
the medical risks of medication, thereby contributing
to the increased quality of the prescription.2,5–8 In
spite of the many beneﬁts of ePrescribing,8 there are
also risks.9 The lack of quality in electronic prescrip-
tions is primarily due to shortcomings in the com-
puterised physician order entry (CPOE) within the
electronic health record (EHR).1,10,11 CPOEs in vari-
ous EHRs diﬀer with respect to design of the user
interface and functionality.
The term usability describes the requirements of a
system and implies the ease with which a product or
system can be used to help the user achieve the desired
goal.12,13 This also implies that usability requires a
certain degree of user-friendliness.14,15
In order to improve the quality of ePrescribing,
there is a need to evaluate diﬀerent CPOEs in a
systematic fashion.16 Prescribers’ perceptions of the
features found in their CPOE diﬀer between users
within the same EHR,17 often due to the fact that there
are shortcomings in the system’s usability.
Objective
The objective of this study was to develop amethod to
evaluate the usability of CPOEs for ePrescribing. The
method was then applied to assess EHRs used in
primary care.
Materials and methods
First, in order to formulate quality criteria for
ePrescribing, we designed an evaluation model for
CPOEs by assembling quality criteria from diﬀerent
sources, supplemented with new criteria. Second, we
applied the evaluation model to assess CPOEs for
ePrescribing in seven EHRs in primary care in Sweden.
Materials
The most frequently utilised EHRs in primary care
were selected: Cosmic 7.2 (Cambio Health Care Sys-
tems), Journal III version 1828 (Profdoc), Medidoc
version 5.9.1.9 (Profdoc), Swedestar version 4.9.006
(Tieto), SYSteam Cross version 4.13.411, Take Care
(Profdoc) andVAS version 10.1B02 (Norrbotten County
Council). Assessment was made at seven Swedish
primary care centres.
Method
Development of an evaluation model
We designed ePrescribing quality criteria by assemb-
ling criteria from four sources: (1) e-lak’s quality
description of the basic requirements for an IT sup-
port for quality improvementof ePrescribing;10 (2) the
Medical Products Agency’s prescription requirements
(LFVS 1997:10);18 (3) an expert consensus for com-
parison of ePrescribing systems;16 and (4) based on
the authors’ own experiences of what facilitates and
hinders ePrescribing, new criteria were added. All
criteria, except those assessing the number of mouse
clicks needed to make a prescription, were answered
with a yes/no. The quality criteria were initially cate-
gorised based on the requirements of the medically
qualiﬁed prescriber, i.e. that focus on usability and
those that (or criteria that) have to do with absolute
requirements on the suppliers of EHRs. These criteria
were categorised and re-categorised during the study
until they ﬁnally fell into stable positions and the
categories thus became deﬁnite. When a criterion
belonged to several groups, it was placed according
to its principal characteristic. The model was devel-
oped iteratively during the study, which meant that
the development and evaluation continued in parallel
until all the included CPOEs had been assessed in the
same way. In total, combination of the four sources
resulted in 73 criteria (Appendix A).
Assessment of prescription modules
The assessment of the CPOEs was carried out in
November–December 2008, using the evaluation
model, which is described as the ﬁrst level of the
results.
Interviews with prescribers
In addition to assessment of the various CPOEs,
prescribing primary care physicians were interviewed
about their experiences and attitudes to the various
CPOEs. The questions asked were:
. What do you think is good with your CPOE?
. What do you think is bad with your CPOE?
. What would you like to improve on your CPOE?
The interviews regarding the respective CPOEs in-
cluded between one and four physicians, with a
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majority of women, except for Swedestar where men
formed themajority in the sample. All interviews were
recorded using a digital Dictaphone and transcribed
verbatim. The answers were grouped according to
their face values without any further analysis.
All reviews of the EHRs and interviews with pre-
scribers were made by one of the authors (LJH).
Results
The evaluation model
The model was found to be easy to use, and facilitated
the process of assessment.
The evaluation model included the following ﬁve
categories of quality criteria which all concern the
usability of the CPOE:
. Safety refers to features that aﬀect the quality of the
completed prescription and, from a patient point of
view, contribute to a safer prescription.
. Prescription support includes features that make
prescribing itself easier.
. Decision support includes indicators and functions
that facilitate correct decisions regarding the pre-
scription.
. User-friendliness refers to how intuitive and easy
the systems are to use.
. Patient support refers to functions in the EHR that
facilitate use of the drug for patients.
The evaluation
Evaluation of the EHRs revealed diﬀerences and
similarities between the diﬀerent systems. None of
the CPOEs was perfect in that all had distinct short-
comings. The most prominent deﬁciencies were non-
intuitive interfaces and incorrect dosage function.
By applying the diﬀerent criteria in the evaluating
model, the results belowwere obtained in the diﬀerent
categories.
Safety
Only one patient could be dealt with at the same time
in all but one of the EHRs’ CPOE. The exception was
Medidoc, in which two patient views could be dis-
played simultaneously. For all systems, the patient
identity was clearly displayed in the upper left-hand
corner and throughout the whole prescription pro-
cess. Recording the reason for the prescription was
mandatory in the Take Care system only. The dosage
was prescribed in more or less free text in the majority
of the systems. In Cosmic and Take Care, it was
possible to use diﬀerent ﬁxed dose windows for
diﬀerent types of prescription, such as until further
notice, if necessary, periodic and on–oﬀ prescription.
The cancellation of prescriptions was possible in all
EHRs, and in all of the systems except Swedestar this
feature was intuitive. None of the systems had two-
way communication with the pharmacy.
Prescription support
The reason for the termination of a prescription could
be entered in all systems except Swedestar and SYSteam
Cross andwas onlymandatory in TakeCare. Duration
of treatment was automatically included when the
drug was prescribed for a limited time in Swedestar
and VAS. In Cosmic, the prescriber had to tap a small
box to include the duration of treatment, and in the
other systems, it had to be presented in free text where
the dosage was prescribed. The renewal of all medi-
cations just took a few mouse clicks in Cosmic and
Medidoc only. The recommended drugs were dis-
played in all of the systems. Only VAS alerted the
prescriber to when a non-recommended drug was
being prescribed.
Decision support
Allergy warnings were imperfect in many of the
systems and only linked to the actual prescription in
Medidoc and Cosmic. Integration with web-based
FASS existed in all systems except for VAS and
Swedestar. In SYSteam Cross it was not web-based,
but linked to the Swedish Information System for
Medicines (SIL). Integration with Janus existed in
Journal III, Medidoc and Take Care. The SIL was used
in database format in Medidoc and SYSteam Cross
only. However, most of the other suppliers of EHRs
were working to integrate this function. Coordination
between decision support and a list of laboratory tests
did not exist in any of the systems; thus, warnings
could not be linked to current liver or renal function
tests.
User-friendliness
The number of mouse clicks needed to make a new
prescription varied between ﬁve and 15. In Swedestar
and Journal III, ﬁve mouse clicks only were required,
contrasting with 15 in Take Care; the average in the
other systems was eight. Repeat prescribing was easier
than a new prescription in all systems, although
Medidoc demanded an equal number of mouse clicks
for repeats as for new prescriptions. Usually, between
four and ﬁve mouse clicks were required, Take Care
being an exception requiring nine. The user interface
of VAS was inferior to the other EHRs with several
diﬀerent shades of grey and the dosages written with
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too many zeros. For example, 20 mg was presented as
0020.000 MG which was considered as being indis-
tinct. The systems that use the right mouse button,
as Cosmic and partly also SYSteam Cross, were less
intuitive than those designed to use icons. Apart from
VAS, the interfaces were fairly equivalent in the
diﬀerent systems and in all systems there was room
for improvement.
Patient support
It was possible to print a paper copy of the list of
medications for the patient in all of the systems. This
list was informative and explicit in all systems except
for Swedestar, where it was messy and diﬃcult for the
patient to read.
Summary of the CPOEs’ characteristics
for ePrescribing
Evaluation of the seven CPOEs is summarised as
follows:
. Cosmic: Fairly safe, but not intuitive. Not entirely
suited for primary care.
. Journal III: Easy to use with a few simple mouse
clicks, but lacking important features.
. Medidoc: Easy to use with relatively few mouse
clicks, but lacking some important features.
. Swedestar: Easy to use with a few simple mouse
clicks, but lacking important features.
. SYSteamCross: Fairly easy to use with relatively few
mouse clicks, but lacking some important features.
. Take Care: Fairly safe and intuitive, but many mouse
clicks. Not entirely suited for primary care.
. VAS: Poor interface, lacking some important fea-
tures.
The interviews
In a few cases, the prescribers contributed to new
approaches in the creation of the evaluation model.
The interviews showed that physicians who had
worked with the same system for a long time were
content, whereas those who had recently switched
systems were generally very dissatisﬁed. Changes in
the system had generally been from one used in
primary care only to one that was the same for both
primary and inpatient care.
Discussion
We found that the evaluation model developed in this
study can be utilised as a basis for studying the
usability of CPOEs for ePrescribing. It was easy to
use and revealed diﬀerences and similarities between
the diﬀerent systems. We found that no system was
perfect, and that all had diﬀerent shortcomings.
The components of the evaluation
model
The quality criteria were likely to be reliable and valid
because they were derived from three authority-like
inﬂuential sources, and several of the quality criteria
were present in more than one source. Although the
list was extensive, new quality criteria were added in
all groups as further key areas were identiﬁed. In the
domains of decision support and user-friendliness,
the majority of the criteria were new. These criteria
helped anchor the evaluation model in the reality of
prescribing doctors. Some of the ﬂaws with the existing
systemsmay have been because these new criteria have
been overlooked. When assessing the CPOEs of the
seven EHRs, the evaluationmodel was easy to use, and
facilitated the assessment process.
Limitations of the evaluation process
Some functions could not be checked by the authors
during the evaluation. In order to assess how the EHRs
deal with any disruptions in the electronic prescrip-
tions service, or how shutdowns aﬀect the electronic
prescriptions, it was necessary to ask the system oper-
ators and/or EHR suppliers. Thus, the description of
these functions is provided by the vendors and cannot
be independently validated by the authors.
All system checks and interviewswere carried out by
one of the authors only. Although, we cannot exclude
some variation between diﬀerent observers, we believe
that this would be small because most of the criteria
were rather robust, had been used previously and the
questions were standardised.
The assessment
Safety
Many of the shortcomings of the electronic prescrip-
tions might jeopardise patient safety because of mis-
understandings.We found that the interface and dosage
were of particular importance. The only feature that
we found similar in the various CPOEs was the
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location of the personal code number and name of the
patient.
In most of the systems, the dosage was presented in
free text. This may result in prescriptions being issued
that lack important information for the patient. Dif-
ferent abbreviations that may or may not be com-
monly known may result in a wrong interpretation at
the pharmacy. Several studies suggest that incorrect
dosage is the most common prescription error.19,20
Prescription support
Only in Swedestar and VAS was the duration of
treatment automatically printed on the prescription,
making it time-limited. This means that very often a
pharmacist cannot verify that a prescription is valid
and has to contact the prescribing doctor. With no
time limit for the period of use, themedication list will
often contain prescriptions that are out of date.
In two of the EHRs, renewal of the complete medi-
cation list was possible with very few mouse clicks.
Although time-saving, thismay alsomake it quite easy
to continue prescribing medications without really con-
sidering their beneﬁts, potential harms or interac-
tions.
Decision support
Allergy warnings were linked to prescription issue
in only two of the EHRs. Hence there is high risk of
potentially dangerous prescriptions in the other EHRs,
especially if the prescribers are not aware of this
deﬁciency in allergy warnings.
User-friendliness
The large number of mouse clicks required to make a
prescription implies redundant time for the physician
who furthermore runs the risk of developing ‘mouse
elbow’. Achieving a balance between simplicity for
the prescriber and patient safety can be diﬃcult. The
system with the most safety catches and mandatory
elements, and thus potentially the most safe, was Take
Care. However, it was also the system that required the
most number of mouse clicks and was experienced as
the most cumbersome by users. To meet the needs
of the prescribers, more intuitive systems have to be
developed and an improvement in the dosage func-
tion is needed to reduce the risk of drugs being
prescribed at the incorrect dosage.
The interviews
The number of interviews within the various systems
was low, and the accounts should be regarded as
adding views on the issue of evaluating EHRs rather
than as generalisable results. In future surveys, we
believe that it is of the utmost importance that users’
experiences and views are covered systematically
We found it interesting that those who had worked
for a long time in the same EHR were satisﬁed, whereas
those who had recently changed systems were gener-
ally very dissatisﬁed. Other studies have shown similar
results.7,21 This is probably because people usually
resist being forced to learn new things, but it might
also be ascribed to home blindness. Gradually, one
adapts even to systems that are cumbersome and lack
important features.
The fact that the interviews did not contributemore
to a deepening of the understanding of the EHRs may
indicate that the evaluation model in itself is suﬃcient
to evaluate the CPOEs.
Practical use and the future of the
evaluation model
The evaluation model presented in this study is
suggested for use in recurrent quality assessments of
the CPOEs within ePrescribing. The model might
ultimately contribute to a higher quality in the pre-
scription of drugs, increase patient safety and reduce
costs to society.
In future, similar evaluation models could be ap-
plied for other parts of the EHR. This type of model
that uses standardised criteria might be used when
the authorities22 certify new systems – in addition to
testing systems in simulated and live environments23 –
and also during purchasing or upgrading since it
facilitates the detection of diﬀerences between the
systems. In the long run, this could put pressure on
suppliers and increase the awareness of the purchasers.
We emphasise that the suppliers of EHRs continue
to improve their CPOEs and that prescribers are
involved in this development.
From this study, the most urgent improvements
needed in the CPOE for ePrescribing are development
towards a more consistent and intuitive interface and
an improvement in the dosage function.
Conclusion
The evaluation model developed in this study can be
used as a basis for studying the usability of CPOEs for
electronic prescriptions. The evaluation method was
easy to use and identiﬁed diﬀerences and similarities
between the systems.
No system was perfect, and all had some deﬁ-
ciencies. Some of the existing deﬁciencies may pose
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a risk to patients and are a burden and nuisance for
prescribers in their daily work.
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Appendix A
Assessment of usability for ePrescribing in electronic health records with a new
evaluation model
Source (Reference) Criteria of usability
Safety
e-lak4 a Bell et al.10 Is the name and personal code number presented clearly?
Bell et al. – during all of the prescription?
e-lak Is it possible to have > 1 patient active at the same time?
e-lak Is signing required before the prescription can be sent to the pharmacy?
e-lak Is it mandatory to sign a termination of treatment?
e-lak, LVFS18 Is it mandatory to ﬁll in the cause of prescription?
e-lak Is it possible to invalidate a prescription?
Author Is signing mandatory for invalidation?
e-lak Is the prescription invalidated at the pharmacy?
e-lak Will the system notify that the invalidation is not made at the pharmacy?
e-lak Will you get a receipt that the invalidation has been received?
Author Is the time of duration of treatment included in the prescription?
Author Is it possible to make a ﬁnal check of the prescription?
Is it possible to prescribe drugs in diﬀerent ways
e-lak, LVFS – for a limited amount of time?
e-lak, LVFS – on–oﬀ prescription?
e-lak, LVFS – when indicated?
LVFS Is it mandatory to ﬁll in the maximum day dose
e-lak, LVFS – periodically
Author – after schedule?
e-lak, Bell et al. Is the list of medications the same in in- and outpatient care?
When making a new prescription, is the following presented clearly?
e-lak, LVFS – the name of the drug
e-lak, LVFS – the drug potency
e-lak, LVFS – the dosage
e-lak, LVFS – the ﬁeld of application
e-lak, LVFS – the prescribed amount
e-lak, LVFS – the number of dispenses
e-lak, LVFS – the date of the prescription
e-lak, LVFS – the name of the prescriber
If previously prescribed drugs, is the following presented clearly?
e-lak – the name of the drug
e-lak – the drug potency
e-lak – the dosage
e-lak – the ﬁeld of application
e-lak – the prescribed amount
e-lak – the number of dispenses
e-lak – the date of the prescription
e-lak – the name of the prescriber
e-lak – the date of the termination
e-lak Are e-prescriptions stored at shutdowns?
e-lak Will prescriptions be sent automatically after the shutdown?
e-lak Is it possible to print a paper copy?
e-lak, Bell et al. Are you made aware of disturbances in the e-prescription service?
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Source (Reference) Criteria of usability
Prescription support
Author Is it possible to renew all medications with one key tap?
e-lak Is package size suggested when time of treatment has been stated?
e-lak Is the prize presented clearly?
e-lak Is the size of the package presented?
e-lak Are recommended drugs displayed?
e-lak Is the prescriber made aware when prescribing a non-recommended drug?
e-lak Are generic drugs displayed at the prescription?
Decison support
e-lak Is the IT support integrated with SIL?b
e-lak Is the drug checked against SIL when re-prescription occurs?
Author Are there prescription and decision support?
Bell et al. Are warnings being prioritised according to clinical relevance?
Author – Janusc
Author – FASSd
Author Are there warnings about interactions?
Bell et al. –contraindications?
Author –allergies?
Author – warnings about pregnancy, lactation?
Author Is there coordination between the laboratory test results, kidney–liver
function?
Author Are favourite prescriptions displayed?
Author How are these updated?
e-lak Is it possible to see the historical prescription for a single drug?
e-lak Is this presented by the ATC-code?
e-lak Is it possible to enter the cause of termination of treatment?
User-friendliness
e-lak Is the interface distinct?
e-lak – self-instructional?
Author How many mouse clicks are necessary in order to make a new prescription?
Author How many mouse clicks are necessary in order to make a re-prescription?
Author Is it possible to make a prescription with only keyboard shortcuts and the tab
key?
e-lak Is it easy to terminate a drug?
Author Is the CPOE easy to ﬁnd in the EHR?
Author Is it easy to prescribe drugs?
e-lak Is it easy to re-prescribe drugs?
Author Is it easy to invalidate a prescription?
Patient support
e-lak Is it possible to print a paper copy of the medication list?
e-lak Are the amount prescribed and the number of dispenses shown?
Notes: a e-lak Quality is a Swedish network that was formed to develop electronic communication in the pharmaceutical ﬁeld
between healthcare and the National Cooperation of Pharmacies. The network includes representatives from the Swedish Association
of regions, private health care providers, municipalities, and pharmacies. This network has formed a description of the basic
requirements for an IT support for quality improvement of e-prescription. b Swedish Information System for Medicines is a database
that ensures the quality of drug information. c Janus is a database that contains comprehensive producer-independent drug
information, targeted at doctors and paramedics whose purpose is to contribute to evidence-based and cost eﬀective drug therapy.
It includes addressing diﬀerent kinds of interactions. d FASS contains quality assured information of registered drugs in Sweden for
doctors, patients and veterinarians, provided by the Swedish Pharmaceutical Association Service AB, LIF.
